Founded in 1997, Bio X Cell is a leading U.S.-based biotechnology company specializing in the production of ultra-pure, low-endotoxin monoclonal antibodies for in vivo preclinical research. Renowned for its proprietary InVivoMAb™ and InVivoPlus™ product lines, Bio X Cell offers a comprehensive catalog of antibodies targeting both well-characterized and novel antigens, supporting research in immunology, cancer biology, neuroscience, and more. All products are manufactured in-house at the company's Lebanon, New Hampshire facility, ensuring stringent quality control and consistency. With over 25 years of experience and citations in more than 20,000 publications, Bio X Cell is a trusted partner for academic, governmental, and commercial research institutions worldwide.
